AEON Biopharma Inc. (AEON) 財務データ
*すべての数値は百万単位です
| 期間終了日 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
0.24%5.92 | 5.93 | 5.51 | 2.49 | 4.34 | |
| Selling, General, and Administrative | 23.37%2.99 | 3.90 | 3.89 | 1.93 | 3.26 |
| Research and Development | 44.44%2.94 | 2.03 | 1.61 | 0.60 | 1.06 |
| Operating Income/Loss | 0.24%-5.92 | -5.93 | -5.51 | -2.49 | -4.34 |
| Nonoperating Income/Loss | 181.30%4.76 | -5.86 | -31.63 | -2.05 | -2.30 |
| Income/Loss From Continuing Operations Before Tax | 90.21%-1.16 | -11.79 | -37.14 | -4.54 | -6.64 |
90.21%-1.16 | -11.79 | -37.14 | -4.54 | -6.64 | |
| Attributable To Parent | 90.21%-1.16 | -11.79 | -37.14 | -4.54 | -6.64 |
| Basic Average Shares | 24.42%50.53 | 40.61 | - | 11.63 | 11.09 |
| Diluted Average Shares | 24.42%50.53 | 40.61 | - | 11.63 | 11.09 |
| Basic Earnings Per Share | 93.10%-0.02 | -0.29 | - | -0.39 | -0.60 |
| Diluted Earnings Per Share | 93.10%-0.02 | -0.29 | - | -0.39 | -0.60 |